Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 5, 2011, Pages 953-958

  Hollestelle, M J ^a   Loots, C M ^b   Squizzato, A ^b,c   Renne T ^d   Bouma, B J ^b   De Groot, P G ^a   Lenting, P J ^a,e   Meijers, J C M ^b   Gerdes, V E A ^b,f  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Dept Environ Med Natl Inst Publ HIth   (Norway)

^f SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Aortic stenosis; Platelet; Von Willebrand factor; Von Willebrand factor propeptide

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; AORTA PRESSURE; AORTA STENOSIS; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SHEAR STRESS; THROMBOCYTE FUNCTION;

ADAM PROTEINS; AGED; AORTIC VALVE STENOSIS; FEMALE; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PLATELET FUNCTION TESTS; QUESTIONNAIRES; SHEAR STRENGTH; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 79955671535     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04247.x     Document Type: Article

References (23)

1. King RM, Pluth JR, Giuliani ER. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg 1987; 44: 514-16.
2. Cappell MS, Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Ann Intern Med 1986; 105: 54-7.
3. Anderson RP, McGrath K, Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement. Lancet 1996; 347: 689-90.
4. Vincentelli A, Susen S, Le TT, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-9.
5. Prohaska W, Zittermann A, Luth JU, Inoue K, Koster-Eiserfunke W, Baller D, Korfer R, Kleesiek K. Prevalent platelet dysfunction in patients with aortic valve disease. J Heart Valve Dis 2008; 17: 542-7.
6. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 1992; 340: 35-7.
7. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 2009; 324: 1330-4.
8. Baldauf C, Schneppenheim R, Stacklies W, Obser T, Pieconka A, Schneppenheim S, Budde U, Zhou J, Grater F. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost 2009; 7: 2096-105.
9. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000; 102: 1290-5.
10. Undas A, Windyga J, Bykowska K, Dimitrow PP, Stepien E, Sadowski J. Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis. Thromb Haemost 2009; 101: 773-4.
11. Dimitrow PP, Hlawaty M, Undas A, Sniezek-Maciejewska M, Sobien B, Stepien E, Tracz W. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis 2009; 204: e103-8.
12. Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, Lopez JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002; 99: 3971-7.
13. Groot E, Fijnheer R, Sebastian SA, de Groot PG, Lenting PJ. The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission. J Thromb Haemost 2009; 7: 962-9.
14. Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 2005; 106: 3035-42.
15. Groot E, de Groot PG, Fijnheer R, Lenting PJ. The presence of active von Willebrand factor under various pathological conditions. Curr Opin Hematol 2007; 14: 284-9.
16. Rapaport SI. Preoperative hemostatic evaluation: which tests, if any? Blood 1983; 61: 229-31.
17. van Schooten CJ, Denis CV, Lisman T, Eikenboom JC, Leebeek FW, Goudemand J, Fressinaud E, van den Berg HM, de Groot PG, Lenting PJ. Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. Blood 2007; 109: 2430-7.
18. Groot E, Hulstein JJ, Rison CN, de Groot PG, Fijnheer R. FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 4: 698-9.
19. Snoep JD, Roest M, Barendrecht AD, de Groot PG, Rosendaal FR, van der Bom JG. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study. J Thromb Haemost 2010; 8: 906-13.
20. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202.
21. O'Brien JR, Tsai HM, Etherington MD. Defective von Willebrand factor activity detected by the filterometer in three clinical conditions. Platelets 2000; 11: 388-94.
22. Imai K, Okura H, Kume T, Yamada R, Miyamoto Y, Kawamoto T, Watanabe N, Neishi Y, Toyota E, Yoshida K. C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J 2008; 156: 713-18.
23. Sanchez PL, Santos JL, Kaski JC, Cruz I, Arribas A, Villacorta E, Cascon M, Palacios IF, Martin-Luengo C. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006; 97: 90-3.